PTC Therapeutics

PTCT

0 Followers

$46.39

+0.83%

$0.38

14 August

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

PTCT Fair Price

$49.07

Overvalued by 41.0%

To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

PTC Therapeutics, Inc. is an American biotechnology company that specializes in the development and commercialization of drugs for genetic and rare diseases. Founded in 1998, the company focuses on molecular therapies and innovative approaches to treating conditions that lack sufficient treatment options. PTC Therapeutics is dedicated to researching and developing drugs that target the genetic mechanisms of diseases, including conditions like Duchenne muscular dystrophy and other rare genetic disorders. The company has a global reach, with its drugs distributed in various countries.

Feed

There are no posts to show right now.